SCHRODINGER INC (SDGR) Stock News

NASDAQ:SDGR - Nasdaq - US80810D1037 - Common Stock - Currency: USD

19.21 -0.15 (-0.77%)

After market: 19.3 +0.09 (+0.47%)

Technical Analysis

Fundamental Analysis

Analyst Ratings

Earnings Estimates

SDGR Latest News, Press Relases and Analysis

All

Press Releases

3 days ago - By: Zacks Investment Research - Mentions: VEEV

Schrodinger, Inc. (SDGR) Reports Q2 Loss, Beats Revenue Estimates

3 days ago - By: The Motley Fool - Mentions: NVS

Schrödinger (SDGR) Q2 2025 Earnings Transcript

3 days ago - By: Schrödinger

Schrödinger Reports Second Quarter 2025 Financial Results

3 days ago - By: Benzinga - Mentions: OEC VTLE DIN INSE ...

Earnings Scheduled For August 6, 2025

4 days ago - By: Zacks Investment Research - Mentions: CLOV

Clover Health Investments, Corp. (CLOV) Q2 Earnings Meet Estimates

8 days ago - By: Zacks Investment Research - Mentions: VEEV

Can Veeva's Vault R&D Keep Its Lead Amid Rising AI Competition?

15 days ago - By: Schrödinger

Schrödinger to Announce Second Quarter 2025 Financial Results on August 6

22 days ago - By: Schrödinger

Schrödinger Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4)

23 days ago - By: Schrödinger

Ajax Therapeutics and Schrödinger Expand Research Collaboration to Include Additional JAK Target

24 days ago - By: Zacks Investment Research - Mentions: RLAY RXRX

Can Recursion Pharmaceuticals' Strategic Deals Fuel Long-Term Growth?

a month ago - By: Zacks Investment Research - Mentions: RLAY RXRX

Will RXRX's Shift in Pipeline Focus Help Restore Investor Faith?

a month ago - By: Pomerantz LLP

INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Schrödinger, Inc. - SDGR

a month ago - By: Yahoo Finance

Schrödinger (SDGR) Receives FDA Fast Track Designation for Cancer Drug SGR-1505

a month ago - By: Yahoo Finance - Mentions: PNC FDX AMZN UPS ...

Meta upgraded, PNC Financial downgraded: Wall Street's top analyst calls

a month ago - By: Pomerantz LLP

INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Schrödinger, Inc. - SDGR

a month ago - By: Pomerantz LLP

INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Schrödinger, Inc. - SDGR

a month ago - By: ACCESS Newswire

INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Schrödinger, Inc. - SDGR

a month ago - By: Pomerantz LLP

INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Schrödinger, Inc. - SDGR

a month ago - By: Schrödinger

Schrödinger Receives Fast Track Designation for SGR-1505 for the Treatment of Relapsed/Refractory Waldenström Macroglobulinemia

a month ago - By: ACCESS Newswire

INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Schrödinger, Inc. - SDGR

2 months ago - By: ACCESS Newswire

INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Schrödinger, Inc. - SDGR

2 months ago - By: ACCESS Newswire

INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Schrödinger, Inc. - SDGR

2 months ago - By: Pomerantz LLP

INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Schrödinger, Inc. - SDGR

2 months ago - By: Pomerantz LLP

INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Schrödinger, Inc. - SDGR

2 months ago - By: ACCESS Newswire

INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Schrödinger, Inc. - SDGR

2 months ago - By: Pomerantz LLP

INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Schrödinger, Inc. - SDGR

2 months ago - By: Schrödinger

Schrödinger Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4)

2 months ago - By: Pomerantz LLP

INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Schrödinger, Inc. - SDGR

2 months ago - By: Schrödinger

Schrödinger Reports Encouraging Initial Phase 1 Clinical Data for SGR-1505 at EHA Annual Congress

2 months ago - By: Pomerantz LLP

INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Schrödinger, Inc. - SDGR

2 months ago - By: Pomerantz LLP

INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Schrödinger, Inc. - SDGR

2 months ago - By: Pomerantz LLP

INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Schrödinger, Inc. - SDGR

2 months ago - By: Schrödinger

Schrödinger Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4) to Newly Appointed Chief Commercial Officer

2 months ago - By: Schrödinger

Schrödinger Expands Executive Leadership Team with Appointment of Mannix Aklian as Chief Commercial Officer, Global Head of Software Sales and Marketing

2 months ago - By: Pomerantz LLP

INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Schrödinger, Inc. - SDGR

2 months ago - By: Zacks Investment Research - Mentions: SNY LLY RXRX

RXRX vs. SDGR: Which AI-Powered Drug Discovery Stock Has More Upside?

3 months ago - By: Schrödinger

Schrödinger Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4)

3 months ago - By: Schrödinger

Schrödinger to Present at Jefferies Global Healthcare Conference

3 months ago - By: Yahoo Finance - Mentions: MS BILI HD WDAY ...

Leadership Transition at Schrödinger: Richie Jain Named CFO

3 months ago - By: Yahoo Finance - Mentions: NVDA CRWD GMAB FFIV ...

CrowdStrike Strengthens AI Security with NVIDIA Enterprise AI Factory Integration